NO161917C - Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av tieno- og furo-(2,3-c)-pyrroler. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av tieno- og furo-(2,3-c)-pyrroler.

Info

Publication number
NO161917C
NO161917C NO854051A NO854051A NO161917C NO 161917 C NO161917 C NO 161917C NO 854051 A NO854051 A NO 854051A NO 854051 A NO854051 A NO 854051A NO 161917 C NO161917 C NO 161917C
Authority
NO
Norway
Prior art keywords
tieno
pyroles
furo
preparation
active derivatives
Prior art date
Application number
NO854051A
Other languages
English (en)
Other versions
NO161917B (no
NO854051L (no
Inventor
Didier Festal
Denis Descours
Jean-Claude Depin
Yvette Quentin
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of NO854051L publication Critical patent/NO854051L/no
Publication of NO161917B publication Critical patent/NO161917B/no
Publication of NO161917C publication Critical patent/NO161917C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO854051A 1984-10-12 1985-10-11 Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av tieno- og furo-(2,3-c)-pyrroler. NO161917C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8415658A FR2571723B1 (fr) 1984-10-12 1984-10-12 Derives de thieno et furo-(2,3-c) pyrroles, procedes de preparation et medicaments les contenant

Publications (3)

Publication Number Publication Date
NO854051L NO854051L (no) 1986-04-14
NO161917B NO161917B (no) 1989-07-03
NO161917C true NO161917C (no) 1989-10-11

Family

ID=9308598

Family Applications (1)

Application Number Title Priority Date Filing Date
NO854051A NO161917C (no) 1984-10-12 1985-10-11 Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av tieno- og furo-(2,3-c)-pyrroler.

Country Status (19)

Country Link
EP (1) EP0180500A1 (no)
JP (1) JPS6197286A (no)
AU (1) AU593776B2 (no)
CA (1) CA1250847A (no)
CS (1) CS265211B2 (no)
DD (1) DD237662A5 (no)
DK (1) DK465685A (no)
ES (1) ES8605524A1 (no)
FR (1) FR2571723B1 (no)
HU (1) HU193827B (no)
IL (1) IL76619A (no)
IN (1) IN169684B (no)
MA (1) MA20543A1 (no)
NO (1) NO161917C (no)
OA (1) OA08119A (no)
PT (1) PT81282B (no)
SU (1) SU1329621A3 (no)
YU (1) YU162485A (no)
ZA (1) ZA857809B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
FR2733750B1 (fr) * 1995-05-03 1997-06-13 Synthelabo Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
ATE325125T1 (de) 2002-09-06 2006-06-15 Janssen Pharmaceutica Nv Thienopyrrolyl und furanopyrrolyl verbindungen und deren verwendung als histamin h4 rezeptor liganden
CN101186612B (zh) * 2006-11-15 2012-10-03 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的吡咯啉衍生物及其制备和应用
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
GB1601459A (en) * 1977-05-17 1981-10-28 Allen & Hanburys Ltd Aminoalkyl thiophene derivatives
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses

Also Published As

Publication number Publication date
CS265211B2 (en) 1989-10-13
NO161917B (no) 1989-07-03
IN169684B (no) 1991-12-07
DK465685A (da) 1986-04-13
FR2571723B1 (fr) 1988-08-26
PT81282A (fr) 1985-11-01
CA1250847A (fr) 1989-03-07
YU162485A (en) 1987-12-31
ZA857809B (en) 1986-05-28
EP0180500A1 (fr) 1986-05-07
ES8605524A1 (es) 1986-03-16
JPS6197286A (ja) 1986-05-15
HUT40133A (en) 1986-11-28
DK465685D0 (da) 1985-10-11
AU593776B2 (en) 1990-02-22
ES547789A0 (es) 1986-03-16
NO854051L (no) 1986-04-14
HU193827B (en) 1987-12-28
DD237662A5 (de) 1986-07-23
FR2571723A1 (fr) 1986-04-18
IL76619A (en) 1990-07-12
IL76619A0 (en) 1986-02-28
SU1329621A3 (ru) 1987-08-07
CS714485A2 (en) 1988-08-16
MA20543A1 (fr) 1986-07-01
OA08119A (fr) 1987-03-31
AU4852885A (en) 1986-04-17
PT81282B (pt) 1988-02-17

Similar Documents

Publication Publication Date Title
NO161370C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridin-derivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO162514C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO852885L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin-, kinolon- og pyridobenzoksazin-derivater.
NO870526L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO161802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO160369C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive 1,3-dihydro-6-(1-hydroksy-2-dimetylaminometyl-allyl)-7-hydroksy-furo(3,4-c)-pyridinderivater.
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO162721C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridinderivater.
NO863671D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-2-heterocykloalkylpyrido(4,3)indoler.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO864131D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO161917C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av tieno- og furo-(2,3-c)-pyrroler.
NO168040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3'-demetoksyepipodofyllotoksin-glukosidderivater.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.